SG11201608935TA - Infectious plasmodium sporozoites grown in vitro - Google Patents

Infectious plasmodium sporozoites grown in vitro

Info

Publication number
SG11201608935TA
SG11201608935TA SG11201608935TA SG11201608935TA SG11201608935TA SG 11201608935T A SG11201608935T A SG 11201608935TA SG 11201608935T A SG11201608935T A SG 11201608935TA SG 11201608935T A SG11201608935T A SG 11201608935TA SG 11201608935T A SG11201608935T A SG 11201608935TA
Authority
SG
Singapore
Prior art keywords
vitro
grown
plasmodium sporozoites
infectious plasmodium
infectious
Prior art date
Application number
SG11201608935TA
Inventor
Abraham G Eappen
Stephen L Hoffman
Original Assignee
Sanaria Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanaria Inc filed Critical Sanaria Inc
Publication of SG11201608935TA publication Critical patent/SG11201608935TA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/002Protozoa antigens
    • A61K39/015Hemosporidia antigens, e.g. Plasmodium antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • A61P33/12Schistosomicides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/10Protozoa; Culture media therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG11201608935TA 2014-05-02 2015-05-01 Infectious plasmodium sporozoites grown in vitro SG11201608935TA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461987834P 2014-05-02 2014-05-02
US201462016981P 2014-06-25 2014-06-25
PCT/US2015/028890 WO2015168620A1 (en) 2014-05-02 2015-05-01 Infectious plasmodium sporozoites grown in vitro

Publications (1)

Publication Number Publication Date
SG11201608935TA true SG11201608935TA (en) 2016-11-29

Family

ID=54359397

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201608935TA SG11201608935TA (en) 2014-05-02 2015-05-01 Infectious plasmodium sporozoites grown in vitro
SG10201900876VA SG10201900876VA (en) 2014-05-02 2015-05-01 Infectious plasmodium sporozoites grown in vitro

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10201900876VA SG10201900876VA (en) 2014-05-02 2015-05-01 Infectious plasmodium sporozoites grown in vitro

Country Status (12)

Country Link
US (5) US9878026B2 (en)
EP (1) EP3137106B1 (en)
JP (2) JP7021851B2 (en)
KR (1) KR102467128B1 (en)
CN (1) CN106413746A (en)
AP (1) AP2016009590A0 (en)
AU (1) AU2015252843B2 (en)
CA (1) CA2947595A1 (en)
ES (1) ES2954144T3 (en)
IL (1) IL248500B (en)
SG (2) SG11201608935TA (en)
WO (1) WO2015168620A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102467128B1 (en) 2014-05-02 2022-11-15 사나리아 인코퍼레이티드 Infectious plasmodium sporozoites grown in vitro
WO2016141270A2 (en) 2015-03-04 2016-09-09 Sanaria Inc. Serum antibody assay for determining protection from malaria, and pre-erythrocytic subunit vaccines
US11332711B1 (en) 2018-04-05 2022-05-17 University Of South Florida Sporozoite cryopreservation compositions and methods

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4824671A (en) * 1986-03-24 1989-04-25 Reuter Laboratories, Inc. In vitro method for producing infective bacterial spores and spore-containing insecticidal compositions
AU2001293074A1 (en) 2000-09-25 2002-04-08 Walter Reed Army Institute Of Research Human liver cell line
AU2003221694A1 (en) * 2002-04-05 2003-10-27 Stephen L Hoffman Apparatuses and methods for the production of haematophagous organisms and parasites suitable for vaccine production
US8802919B2 (en) 2002-04-05 2014-08-12 Sanaria Inc. Apparatuses and methods for the production of haematophagous organisms and parasites suitable for vaccine production
ES2371066T3 (en) * 2002-11-20 2011-12-27 Sanaria Inc. VACCINE FOR THE PREVENTION OF PALUDISM.
US20050208078A1 (en) 2003-11-20 2005-09-22 Hoffman Stephen L Methods for the prevention of malaria
US20050220822A1 (en) * 2003-11-20 2005-10-06 Hoffman Stephen L Methods for the prevention of malaria
EP2128613A1 (en) * 2008-05-28 2009-12-02 Institut Pasteur Method for screening compounds for their ability to increase rigidity of red blood cells infected by a protozoan parasite of the genus plasmodium and application thereof
US8043625B2 (en) 2009-01-16 2011-10-25 Sanaria Inc. Purified plasmodium and vaccine compositions
US20120288525A1 (en) 2011-05-11 2012-11-15 Chakravarty Sumana Pharmaceutical compositions comprising attenuated plasmodium sporozoites and glycolipid adjuvants
EP2956166B1 (en) 2013-01-25 2019-01-16 Sanaria Inc. Genetic attenuation of plasmodium by b9 gene disruption
US20160216276A1 (en) 2013-08-30 2016-07-28 Sanaria Inc. Serum antibody assay for determining protection from malaria, and pre-erythrocytic subunit vaccines
KR102467128B1 (en) 2014-05-02 2022-11-15 사나리아 인코퍼레이티드 Infectious plasmodium sporozoites grown in vitro
WO2016141270A2 (en) 2015-03-04 2016-09-09 Sanaria Inc. Serum antibody assay for determining protection from malaria, and pre-erythrocytic subunit vaccines

Also Published As

Publication number Publication date
WO2015168620A1 (en) 2015-11-05
BR112016025199A8 (en) 2021-07-13
AU2015252843B2 (en) 2020-12-24
IL248500A0 (en) 2016-12-29
US20160287688A1 (en) 2016-10-06
EP3137106A4 (en) 2018-01-17
BR112016025199A2 (en) 2017-08-15
JP7021851B2 (en) 2022-02-17
JP2020141691A (en) 2020-09-10
KR20160147985A (en) 2016-12-23
US9878026B2 (en) 2018-01-30
US20220257742A1 (en) 2022-08-18
JP2017514490A (en) 2017-06-08
US20180161413A1 (en) 2018-06-14
AU2015252843A1 (en) 2016-11-17
US11883475B2 (en) 2024-01-30
ES2954144T3 (en) 2023-11-20
EP3137106B1 (en) 2023-07-05
US11207395B2 (en) 2021-12-28
IL248500B (en) 2022-07-01
US20200113987A1 (en) 2020-04-16
AP2016009590A0 (en) 2016-11-30
CA2947595A1 (en) 2015-11-05
EP3137106A1 (en) 2017-03-08
CN106413746A (en) 2017-02-15
SG10201900876VA (en) 2019-03-28
US10441646B2 (en) 2019-10-15
KR102467128B1 (en) 2022-11-15
US20240173393A1 (en) 2024-05-30

Similar Documents

Publication Publication Date Title
AU353527S (en) Earring
AU355178S (en) Earring
PL3298055T3 (en) Article comprising tubular particles
SG10201709917VA (en) Malaria vaccine
GB201402811D0 (en) Support bars and cycle carriers
GB201318084D0 (en) Malaria vaccination
EP3294863A4 (en) In vitro
AU366930S (en) Flowerpot
IL248500A0 (en) Infectious plasmodium sporozoites grown in vitro
GB201418996D0 (en) Article
GB2531703B (en) Printed article
GB201412554D0 (en) In vitro mesodermal differentiation
IL253174B (en) Nanoparticles and methods for preparation thereof
TWM489595U (en) Intelligent mailbox system and intelligent mailbox
GB201317524D0 (en) Stackable hollow objects
TWM489576U (en) Crib changeable into different use configurations
PT3545109T (en) In vitro
GB201401153D0 (en) In vitro toxocity assays
GB201419163D0 (en) High-visibility article
GB201415791D0 (en) Improvements in frying technology
HK1215135A1 (en) Ornamental articles
GB201518142D0 (en) Concept ABCD3
GB201314845D0 (en) Stackable hollow objects
GB201418787D0 (en) Microcarriers
GB201418789D0 (en) Microcarriers